Claims
- 1. A dye forming composition which forms a color in the presence of hydrogen peroxide comprising a first compound, said first compound selected from the group consisting of: ##STR4## and a second compound selected from the group consisting of hydrazones and 4-aminoantipyrines.
- 2. The dye forming composition according to claim 1 wherein said second compound is a hydrazone.
- 3. The composition according to claim 2 wherein the hydrazonea have formula: ##STR5## wherein R.sup.1 is C.sub.1-4 alkyl; X is S, O or NR.sup.2 ; R.sup.2 is C.sub.1-4 alkyl; and R.sup.1 and R.sup.2 may be the same or different;
- R.sup.3 and R.sup.4 are phenyl, pyridinyl, naphthyl, or quinolinodyl and may be the same or different, or R.sup.3 and R.sup.4 together form a fused benzene, pyridine, naphthalene, or quinoline ring;
- and the saturated ring nitrogen is at a position vicinal to the hydrazone functional group.
- 4. The composition according to claim 2 wherein the hydrazone is selected from the group consisting of 3-methyl-2-benzothiazolinone hydrazone, 1-methyl-2-quinoline hydrazone, N-methyl-pyridone-4-hydrazone, N-methyl-pyridone-2-hydrazone, N-methyl-quinoline-2-hydrazone, N-methyl-quinoline-4-hydrazone, N-methyl-2-benzothiazolinone hydrazone, N-methyl-thiazolinone-2-hydrazone, N-methyl-thiazolinone-2-hydrazone, N-methyl-4-phenylthiazolinone-2-hydrazone, N-methyl-oxazolinone-2-hydrazone, N-methyl-benzoxazolinone-2-hydrazone, 1,3-dimethyl-benzimidazolinone-2-hydrazone, and 3-(C.sub.1-4 alkyl)-2-benzothiazolinone hydrazone.
- 5. The dye forming composition according to claim 1 wherein said second compound is a 4-aminoantipyrine.
- 6. The composition according to claim 5 wherein the hydrazones have the formula: ##STR6## wherein R.sup.5 is C.sub.1-4 alkyl, R.sup.3 and R.sup.4 are phenyl, pyridinyl, naphthyl, or quinolidyl and R.sup.3 and R.sup.4 are the same of different, or R.sup.3 and R.sup.4 together form a fused benzene, pyridine, naphthalene or quinoline ring, and the saturated ring nitrogen is at a position ortho or para to the hydrazone functional group.
- 7. The composition according to claim 5 wherein the 4-aminoantipyrine is selected from the group consisting of 4-aminoantipyrine, 4-(dimethylamino)antipyrine, 4-(ethylamino)antipyrine, 4-(methylamino)antipyrine, 4-(sodium sulfonatomethylamino)antipyrine, 4-)sodiumsulfonatomethyl)(isobutyl)aminoantipyrine, 4-(sodium sulfonatomethyl)(methyl)amino antipyrine, and 4-(isopropyl) amino antipyrine.
- 8. In an assay device which comprises a support and a reagent layer having contained therein a color indicator composition for detecting hydrogen peroxide, the improvement wherein the color composition comprises a combination of a first compound of the formula: ##STR7## and a second compound selected from the group consisting of hydrazones and 4-aminoantipyrines.
- 9. The composition according to claim 8 wherein the hydrazones have the formula: ##STR8## wherein R.sup.5 is C.sub.1-4 alkyl, R.sup.3 and R.sup.4 are phenyl, pyridinyl, naphthyl, or quinolidyl and R.sup.3 and R.sup.4 are the same or different, or R.sup.3 and R.sup.4 together form a fused benzene, pyridine, naphthalene or quinoline ring, and the saturated ring nitrogen is at a position ortho or para to the hydrazone functional group.
- 10. The assay device according to claims 8 wherein said second compound is a hydrazone.
- 11. The assay device according to claim 10 wherein the hydrazone is selected from the group consisting of 3-methyl-2-benzothiazolinone hydrazone, 1-methyl-2-quinoline hydrazone, N-methyl-pyridone-4-hydrazone, N-methyl-pyridone-2-hydrazone, N-methyl-quinoline-2-hydrazone, N-methyl-quinoline-4-hydrazone, N-methyl-2-benzothiazolinone hydrazone, N-methyl-thiazolinone-2-hydrazone, N-methyl-thiazolinone-2-hydrazone, N-methyl-4-phenylthiazolinone-2-hydrazone, N-methyl-oxazolinone-2-hydrazone, N-methyl-benzoxazolinone-2-hydrazone, 1,3-dimethyl-benzimidazolinone-2-hydrazone, and 3-(C.sub.1 -C.sub.4 alkyl)-2-benzothiazolinone hydrazone.
- 12. The assay device according to claim 11 wherein the hydrazone has the formula: ##STR9## wherein R.sup.1 is C.sub.1-4 alkyl; X is S, O, or NR.sup.2 ; R.sup.2 is C.sub.1-4 alkyl; and R.sup.1 and R.sup.2 may be the same or different;
- R.sup.3 and R.sup.4 are phenyl, pyridinyl, naphthyl, or quinolinodyl and may be the same or different, or R.sup.3 and R.sup.4 together form a fused benzene, pyridine, naphthalene, or quinoline ring;
- and the saturated ring nitrogen is at a position vicinal to the hydrazone functional group.
- 13. The assay device according to claim 8 wherein said second compound is a 4-aminoantipyrine.
- 14. The assay device according to claim 13 wherein the 4-aminoantipyrine is selected from the group consisting of 4-aminoantipyrine, 4-(dimethylamino)antipyrine, 4-(ethylamino)antipyrine, 4-(methylamino)antipyrine, 4-(sodium sulfonatomethylamino)antipyrine, 4-(sodiumsulfonatomethyl) (isobutyl)aminoantipyrine, 4-(sodiumsulfonatomethyl) (methyl)amino antipyrine, and 4-(isopropyl) aminoantipyrine.
- 15. A method for determining hydrogen peroxide or an analyte which reacts to produce hydrogen peroxide in an aqueous liquid, said method comprising the steps of:
- in the presence of a substance having peroxidative activity, physically contacting a sample of a liquid with a dye forming composition which forms a color in the presence of hydrogen peroxide, said dye forming composition comprising a first compound, said first compound selected from the group consisting of: ##STR10## and a second compound selected from the group consisting of hydrazones and 4-aminoantipyrines.
- 16. The method according to claim 15 wherein the hydrazonea have the formula: ##STR11## wherein R.sup.1 is C.sub.1-4 alkyl; X is S, O or NR.sup.2 ; R.sup.2 is C.sub.1-4 alkyl; and R.sup.1 and R.sup.2 may be the same or different;
- R.sup.3 and R.sup.4 are phenyl, pyridinyl, naphthyl, or quinolinodyl and may be the same or different, or R.sup.3 and R.sup.4 together form a fused benzene, pyridine, naphthalene, or quinoline ring;
- and the saturated ring nitrogen is at a position vicinal to the hydrazone functional group.
- 17. The composition according to claim 15 wherein the hydrazones have the formula: ##STR12## wherein R.sup.5 is C.sub.1-4 alkyl, R.sup.3 and R.sup.4 are phenyl, pyridinyl, naphthyl, or quinolidyl and R.sup.3 and R.sup.4 are the same or different, or R.sup.3 and R.sup.4 together form a fused benzene, pyridine, naphthalene or quinoline ring, and the saturated ring nitrogen is at a position ortho or para to the hydrazone functional group.
- 18. The method according to claim 15 wherein said analyte is cholesterol and said contacting step occurs in the presence of cholesterol oxidase.
- 19. The method according to claim 15 wherein said analyte is cholesterol and said contacting step occurs in the presence of glucose oxidase.
- 20. The method according to claim 15 wherein said second compound is a hydrazone.
- 21. The method according to claim 20 wherein the second compound is selected from the group consisting of 3-methyl-2-benzothiazolinone hydrazone, 1-methyl-2-quinoline hydrazone, N-methyl-pyridone-4-hydrazone, N-methyl-pyridone-2-hydrazone, N-methyl-quinoline-2-hydrazone, N-methyl-quinoline-4-hydrazone, N-methyl-2-benzothiazolinone hydrazone, N-methyl-thiazolinone-2-hydrazone, N-methyl-thiazolinone-2-hydrazone, N-methyl-4-phenylthiazolinone-2-hydrazone, N-methyl-oxazolinone-2-hydrazone, N-methyl-benzoxazolinone-2-hydrazone, 1,3-dimethyl-benzimidazolinone-2-hydrazone, and 3-(C.sub.1 -C.sub.4 alkyl)-2-benzothiazolinone hydrazone.
- 22. The method according to claim 15 wherein said second compound is a 4-aminoantipyrine.
- 23. The method according to claim 22 wherein the second compound is selected from the group consisting of 4-aminoantipyrine, 4-(dimethylamino)antipyrine, 4-(ethylamino)antipyrine, 4-(methylamino)antipyrine, 4-(sodium sulfonatomethylamino)antipyrine, 4-(sodiumsulfonatomethyl) (isobutyl)amino antipyrine, and 4-(sodium sulfonatomethyl)(methyl)amino antipyrine, and 4-(isopropyl) amino antipyrine.
- 24. The method according to claim 15 wherein said sample contains ascorbic acid.
- 25. The method according to claim 24 wherein said sample contains at least 5 mg/dL ascorbic acid.
- 26. A diagnostic test kit for the determination of hydrogen peroxide, said kit comprising a container means containing:
- a dye forming composition which forms a color in the presence of hydrogen peroxide comprising a first compound, said first compound selected from the group consisting of: ##STR13## and a second compound selected from the group consisting of hydrazones and 4-aminoantipyrines.
- 27. The diagnostic test kit according to claim 26 wherein the hydrazonea have the formula: ##STR14## wherein R.sup.1 is C.sub.1-4 alkyl; X is S, O or NR.sup.2 ; R.sup.2 is C.sub.1-4 alkyl; and R.sup.1 and R.sup.2 may be the same or different;
- R.sup.3 and R.sup.4 are phenyl, pyridinyl, naphthyl, or quinolinodyl and may be the same or different, or R.sup.3 and R.sup.4 together form a fused benzene, pyridine, naphthalene, or quinoline ring;
- and the saturated ring nitrogen is at a position vicinal to the hydrazone functional group.
- 28. The diagnostic test kit according to claim 26 wherein the hydrazones have the formula: ##STR15## wherein R.sup.5 is C.sub.1-4 alkyl, R.sup.3 and R.sup.4 are phenyl, pyridinyl, naphthyl, or quinolidyl and R.sup.3 and R.sup.4 are the same or different, or R.sup.3 and R.sup.4 together form a fused benzene, pyridine, naphthalene or quinoline ring, and the saturated ring nitrogen is at a position ortho or para to the hydrazone functional group.
- 29. The diagnostic kit according to claim 26 wherein said second compound is a hydrazone.
- 30. The diagnostic kit according to claim 29 wherein the second compound is selected from the group consisting of 3-methyl-2-benzothiazolinone hydrazone, 1-methyl-2-quinoline hydrazone, N-ethyl-pyridone-4-hydrazone, N-methyl-pyridone-2-hydrazone, N-methyl-quinoline-2-hydrazone, N-methyl-quinoline-4-hydrazone, N-methyl-2-benzothiazolinone hydrazone, N-methyl-thiazolinone-2-hydrazone, N-methyl-thiazolinone-2-hydrazone, N-methyl-4-phenylthiazolinone-2-hydrazone, N-methyl-oxazolinone-2-hydrazone, N-methyl-benzoxazolinone-2-hydrazone, 1,3-dimethyl-benzimidazolinone hydrazone. benzothiazolinone hydrazone.
- 31. The diagnostic kit according to claim 26 wherein said second compound is a 4-aminoantipyrine.
- 32. The diagnostic kit according to claim 31 wherein the 4-aminoantipyrine is selected from the group consisting of 4-aminoantipyrine, 4-(dimethylamino)antipyrine, 4-(ethylamino)antipyrine, 4-(methylamino)antipyrine, 4-(sodium sulfonatomethylamino)antipyrine, 4-(sodiumsulfonatomethyl)(isobutyl)aminoantipyrine, 4-(sodium sulfonatomethyl)(methyl)amino antipyrine, and 4-(isopropyl) amino antipyrine.
Parent Case Info
This application is a continuation-in-part of Serial No. 08/037,120, filed Mar. 25, 1993 now abandoned.
US Referenced Citations (27)
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
37120 |
Mar 1993 |
|